Insulet | PODD - 营业费用

股票价格
219.84
每天变化
-16.23 -6.88%
每月一次
-10.76%
每年
-13.94%
Q1 预测
229.85


金融业
股票价格
USD
资产
USD 3.19B
现金及等价物
USD 716.1M
销售成本
USD 215.2M
流动资产
USD 1.91B
流动负债
USD 680.1M
债务
USD 1.01B
EBIT
USD 146.3M
EBITDA
USD 194M
员工
3.9K
EPS每股收益
USD 1.44
股本和储备
USD 1.52B
销售毛利
USD 568.6M
债务利息支出
USD 9.2M
利息收入
USD 8.6M
贷款资金
USD 930.8M
市值
USD 15.57B
净收入
USD 101.6M
营业费用
USD 637.5M
营业利润
USD 146.3M
普通股股本
USD 70.35M
PE价格收益
55.08
税前利润
USD 140.2M
销售收入
USD 783.8M
销售和管理费用
USD 331.4M
股票
USD 452.6M
贸易债权人
USD 75M
应收帐款人
USD 516.9M


营业费用 更改 日
Abbott USD 9.21B 17M 2025-12
Align Technology USD 822.85M 11.8M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Cardinal Health USD -2.88B 5M 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Globus Medical USD 645.11M 241.46M 2025-12
ICU Medical USD 514.62M 4.48M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
J&J USD 18.97B 2.38B 2025-12
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Solventum Corp USD 1.89B 3.09B 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
West Pharmaceutical Services USD 642.5M 2.41B 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12